Synthesis and evaluation of Apogossypol atropisomers as potential Bcl-xL antagonists
- 1 January 2009
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 273 (1) , 107-113
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Bcl-2 antagonist apogossypol (NSC736630) displays single-agent activity in Bcl-2–transgenic mice and has superior efficacy with less toxicity compared with gossypol (NSC19048)Blood, 2008
- Quantitative determination of apogossypol, a pro-apoptotic analog of gossypol, in mouse plasma using LC/MS/MSJournal of Pharmaceutical and Biomedical Analysis, 2006
- Rational Design and Real Time, In-Cell Detection of the Proapoptotic Activity of a Novel Compound Targeting Bcl-XLChemistry & Biology, 2004
- Apoptosis-based therapiesNature Reviews Drug Discovery, 2002
- ApoptosisCell, 2002
- Bcl-2 family proteinsOncogene, 1998
- The Bcl-2 Protein Family: Arbiters of Cell SurvivalScience, 1998
- Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. CohenJournal of Molecular Biology, 1997
- Structure of Bcl-x L -Bak Peptide Complex: Recognition Between Regulators of ApoptosisScience, 1997
- Texture mapping: A new tool for molecular graphicsJournal of Molecular Graphics, 1994